Adendra Therapeutics

United Kingdom
Newdigate, England, United Kingdom, N1C 4AG

Company profile

Adendra Therapeutics company profile

Adendra is an emerging biotechnology company building on new insights into dendritic cell biology to discover and develop new small molecule and biologic medicines for the treatment of a wide range of cancers and autoimmune diseases.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2021-01-01, Year

Headquarters

Postal code
N1C 4AG
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$53M
Last funding
Series A / $53M / 2021-12-07
Last equity funding
Series A / $53M
Investors
1
Lead investors
1
Founders
2

Founders and investors

Founders

Caetano Reis e SousaRaj Mehta

Lead investors

Apple Tree Partners

Investors

Apple Tree Partners